Serial Number:
88064146
Mark:
M
Status:
Registered
Status Date:
06-01-2021
Filing Date:
Registration Number:
6367149
Registration Date:
06-01-2021
Manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies for others; Custom manufacturing of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for the treatment of infectious diseases, chronic diseases and cancer Wholesale store, retail store, and online retail store services featuring pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies Research and development in the field of vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates
Mark Description:
The mark consists of a stylized letter "M". The two outside legs of the "M" are in blue and gradually fade to turquoise and green in the center of the "M". The color white is background of the mark and is not claimed as a feature of the mark.
Class:
Scientific and technological services
Type of Mark:
Trademark
Published for Opposition Date:
03-16-2021
Owner:
Mark Drawing Status:
Words, Letters, and/or Numbers in Stylized From
Abandon Date:
N/A
Business Name:
CANTOR COLBURN LLP
Correspondent Name:
